Maat Pharma SacaMATPF
13F holders, Q3 2024 (September 30)1holders
$7.42avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Maat Pharma Saca (MATPF) in their 13F filings. The largest holder was Propel Bio Management, LLC ($18K).
- Company
- Maat Pharma Saca
- CUSIP
- F5888J116
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $18K |
| Exits | 0 | $0 |
Ownership 1 holders
| Propel Bio Management, LLC | 0.01% | New | 2,397 | $18K |
"% of holder's portfolio" is MATPF's weight in each manager's 13F, not the share of Maat Pharma Saca the manager owns.